Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
1.
Klin Padiatr ; 226(4): 211-5, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25010126

RESUMEN

BACKGROUND: Intravenous sildenafil treatment has recently shown promising results and good tolerability in the treatment of refractory pulmonary hypertension (PH) in term and near-term neonates, while comparable data in preterm infants are still lacking. However, for critically ill preterm infants suffering from PH refractory to conventional treatment, sildenafil may represent a last treatment resort. PATIENTS AND METHODS: We reviewed the records of 6 critically ill extremely preterm infants who had suffered from PH refractory to conventional treatment and had obtained intravenous sildenafil after careful consideration as ultima ratio treatment. AIM: To describe the responses to sildenafil in terms of hemodynamic and respiratory changes during treatment and outcome. RESULTS: 4/6 patients showed resolution of severe PH with full reversal of ductal shunt direction into pure left-to-right shunt within 82 ± 35 h after sildenafil start. Remarkably, 2/6 patients developed pulmonary hemorrhage at a time point when significant improvement of PH had already taken place, both of them survived. Overall 4/6 patients died, two deaths were related to treatment-refractory PH. CONCLUSION: Intravenous sildenafil treatment seems effective in improving severe PH and hemodynamic instability in extremely preterm infants with refractory PH. Pulmonary hemorrhage may represent a distinct adverse effect of sildenafil treatment in these patients, presumably due to sudden reversal of ductal shunt. Accordingly, sildenafil should be restricted to most severe and refractory cases in this population.


Asunto(s)
Recien Nacido con Peso al Nacer Extremadamente Bajo , Enfermedades del Prematuro/tratamiento farmacológico , Síndrome de Circulación Fetal Persistente/tratamiento farmacológico , Piperazinas/administración & dosificación , Sulfonamidas/administración & dosificación , Vasodilatadores/administración & dosificación , Femenino , Hemorragia/inducido químicamente , Hemorragia/diagnóstico , Humanos , Recién Nacido , Enfermedades del Prematuro/diagnóstico , Infusiones Intravenosas , Unidades de Cuidado Intensivo Neonatal , Enfermedades Pulmonares/inducido químicamente , Enfermedades Pulmonares/diagnóstico , Masculino , Síndrome de Circulación Fetal Persistente/diagnóstico , Piperazinas/efectos adversos , Presión Esfenoidal Pulmonar/efectos de los fármacos , Purinas/administración & dosificación , Purinas/efectos adversos , Estudios Retrospectivos , Citrato de Sildenafil , Sulfonamidas/efectos adversos , Vasodilatadores/efectos adversos
2.
Childs Nerv Syst ; 28(12): 2085-92, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22914924

RESUMEN

PURPOSE: Despite a decreasing incidence, intraventricular hemorrhage (IVH) remains a point of major concern in neonatology due to its association to adverse neurodevelopmental outcome (NDO). Aim of this study was to compare outcome of preterm infants with different grades of IVH born below 32 weeks of gestational age (GA) with outcome of controls without IVH and to especially evaluate the influence of low grade IVH on NDO. METHODS: Four hundred seventy-one preterm infants with a GA below 32 weeks were admitted to our neonatal intensive care unit between 1994 and 2005 and included into analysis. RESULTS: IVH patients showed significantly lower mean psychomotor and mental developmental indices and a significantly higher percentage of cerebral palsy and visual impairment. Results of IVH patients born below 28 weeks of GA were significantly worse than results of IVH patients born at or above 28 weeks of GA. In all parameters, an increase of abnormal results with increasing grade of IVH could be observed; even patients with low-grade IVH (grades I and II) showed higher percentages of impairment compared to controls without any IVH. CONCLUSION: Even low-grade IVH has an significant impact on neurodevelopmental outcome of preterm patients and gestational age influences the impact of intraventricular hemorrhage on neurodevelopmental outcome.


Asunto(s)
Ventrículos Cerebrales , Desarrollo Infantil/fisiología , Recien Nacido Prematuro/fisiología , Hemorragias Intracraneales/psicología , Envejecimiento/fisiología , Peso al Nacer , Parálisis Cerebral/etiología , Estudios de Cohortes , Femenino , Edad Gestacional , Humanos , Lactante , Recién Nacido , Hemorragias Intracraneales/complicaciones , Masculino , Enfermedades del Sistema Nervioso/epidemiología , Pruebas Neuropsicológicas , Trastornos de la Visión/etiología
3.
Diabetologia ; 53(6): 1057-61, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20213235

RESUMEN

AIM: The aim of the study was to analyse the prevalence of diabetic onset ketoacidosis (DKA) during a period of 20 years (1989-2008) on a population basis in the whole of Austria. METHODS: A prospective population-based incidence study (1989-2008) was performed. The registered data set comprised blood glucose, pH, ketonuria and clinical symptoms of DKA at manifestation. DKA was defined as pH < 7.3 and severe DKA as pH < 7.1. Time trends were estimated using linear regression models. RESULTS: During the study period, 3331 children <15 years of age (1,797 boys and 1,534 girls) were registered with newly diagnosed type 1 diabetes. Of these, 1,238 (37.2%) presented with DKA, 855 (25.7%) had a mild and 383 (11.5%) a severe form, and one patient died at onset. DKA frequency was negatively associated with age at onset (p < 0.0001). In children <2 years the prevalence was 60%, with a higher risk for girls (70% vs 54% for boys, p < 0.05). Despite a significant increase in diabetes incidence in Austria during the observation period from 8.4 to 18.4/100,000 (p < 0.0001), no significant change in the prevalence of DKA at manifestation was observed. CONCLUSIONS: The overall frequency of DKA in children with newly diagnosed type 1 diabetes in Austria is high and has not changed during the last 20 years despite a clear increase in the manifestation rate. In particular, children less than 2 years of age have a high risk of DKA at onset.


Asunto(s)
Diabetes Mellitus Tipo 1/diagnóstico , Cetoacidosis Diabética/diagnóstico , Cetoacidosis Diabética/epidemiología , Adolescente , Factores de Edad , Edad de Inicio , Austria/epidemiología , Glucemia , Niño , Preescolar , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Masculino , Prevalencia , Estudios Prospectivos , Análisis de Regresión , Índice de Severidad de la Enfermedad
4.
Diabetologia ; 53(4): 641-51, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20063147

RESUMEN

AIMS/HYPOTHESIS: We investigated whether children who are heavier at birth have an increased risk of type 1 diabetes. METHODS: Relevant studies published before February 2009 were identified from literature searches using MEDLINE, Web of Science and EMBASE. Authors of all studies containing relevant data were contacted and asked to provide individual patient data or conduct pre-specified analyses. Risk estimates of type 1 diabetes by category of birthweight were calculated for each study, before and after adjustment for potential confounders.Meta-analysis techniques were then used to derive combined ORs and investigate heterogeneity between studies. RESULTS: Data were available for 29 predominantly European studies (five cohort, 24 case-control studies), including 12,807 cases of type 1 diabetes. Overall, studies consistently demonstrated that children with birthweight from 3.5 to 4 kg had an increased risk of diabetes of 6% (OR 1.06 [95% CI 1.01-1.11]; p=0.02) and children with birthweight over 4 kg had an increased risk of 10% (OR 1.10 [95% CI 1.04-1.19]; p=0.003), compared with children weighing 3.0 to 3.5 kg at birth. This corresponded to a linear increase in diabetes risk of 3% per 500 g increase in birthweight (OR 1.03 [95% CI 1.00-1.06]; p=0.03). Adjustments for potential confounders such as gestational age, maternal age, birth order, Caesarean section, breastfeeding and maternal diabetes had little effect on these findings. CONCLUSIONS/INTERPRETATION: Children who are heavier at birth have a significant and consistent, but relatively small increase in risk of type 1 diabetes.


Asunto(s)
Peso al Nacer , Diabetes Mellitus Tipo 1/epidemiología , Adolescente , Edad de Inicio , Orden de Nacimiento , Niño , Preescolar , Femenino , Edad Gestacional , Humanos , Lactante , Recién Nacido , Edad Materna , Embarazo , Factores de Riesgo
5.
Eur Psychiatry ; 63(1): e55, 2020 05 11.
Artículo en Inglés | MEDLINE | ID: mdl-32389135

RESUMEN

BACKGROUND: Seasonal patterns in hospitalizations have been observed in various psychiatric disorders, however, it is unclear whether they also exist in schizophrenia. Previous studies found mixed results and those reporting the presence of seasonality differ regarding the characteristics of these patterns. Further, they are inconclusive whether sex is an influencing factor. The aim of this study was therefore to examine if seasonal patterns in hospitalizations can be found in schizophrenia, with special regard to a possible influence of sex, by using a large national dataset. METHODS: Data on all hospital admissions within Austria due to schizophrenia (F20.0-F20.6) for the time period of 2003-2016 were included. Age standardized monthly variation of hospitalization for women and men was analyzed and the level of significance adjusted for multiple testing. RESULTS: The database comprised of 110,735 admissions (59.6% men). Significant seasonal variations were found in the total sample with hospitalization peaks in January and June and a trough in December (p < 0.0001). No significant difference in these patterns was found between women and men with schizophrenia (p < 0.0001). CONCLUSION: Our study shows that schizophrenia-related hospitalizations follow a seasonal pattern in both men and women. The distribution of peaks might be influenced by photoperiod changes which trigger worsening of symptoms and lead to exacerbations in schizophrenia. Further research is necessary to identify underlying factors influencing seasonal patterns and to assess whether a subgroup of patients with schizophrenia is especially vulnerable to the impact of seasonal variations.


Asunto(s)
Admisión del Paciente/estadística & datos numéricos , Sistema de Registros/estadística & datos numéricos , Esquizofrenia/epidemiología , Estaciones del Año , Adulto , Austria , Femenino , Humanos , Masculino , Persona de Mediana Edad , Esquizofrenia/terapia , Índice de Severidad de la Enfermedad , Adulto Joven
6.
J Affect Disord ; 262: 304-309, 2020 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-31733918

RESUMEN

BACKGROUND: Given the high burden and prevalence of depression, various guidelines underscore the role of healthcare providers in supplying advice on physical activity (PA) as a potential modifying factor influencing the incidence and severity of depressive symptoms in adults. We aimed to investigate the extent to which healthcare providers provide PA advice to adults with depressive symptoms in the US. METHODS: Data on adults aged 20-64 years (n = 4971) in the National Health and Nutrition Examination Study between 2011 and 2016 were analysed. Depressive symptoms were assessed using the Patient Health Questionnaire and response options were categorised as "none or minimal", "mild", "moderate-severe". Receipt of PA advice from a healthcare provider was self-reported. We restricted our study sample to adults free from chronic diseases. RESULTS: Higher odds of receiving advice to exercise were reported among adults with mild (OR = 1.7, 95% CI: 1.3-2.3) and moderate-severe depressive symptoms (OR = 1.7, 95% CI: 1.0-2.8). Furthermore, exercise advice was more commonly reported among adults who were overweight, obese, Hispanic, Asian, being insured with private insurance, with education higher than high school, and had access to a routine place for health care. LIMITATIONS: Social and culutral aspects of overweight/obesity may prohibit generalizations. Cross sectional design does not allow for causal realtionships. CONCLUSIONS: In the US, fewer than one in three adults experiencing symptoms of depression report having received exercise advice from a healthcare provider. Providing such advice may be a sustainable clinical strategy in reducing the incidence and severity of depression symptoms.


Asunto(s)
Consejo/estadística & datos numéricos , Depresión/terapia , Personal de Salud/psicología , Pautas de la Práctica en Medicina/estadística & datos numéricos , Rol Profesional/psicología , Adulto , Estudios Transversales , Depresión/psicología , Ejercicio Físico/psicología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Encuestas Nutricionales , Prevalencia , Autoinforme , Estados Unidos/epidemiología , Adulto Joven
7.
Haemophilia ; 15(4): 888-93, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19473415

RESUMEN

Survival of patients with haemophilia is still a relevant issue of great interest. A survival analysis was conducted among 226 patients with haemophilia A and B (128 severe haemophiliacs), who were treated at the haemophilia care centre in Vienna. Information on mortality in our patient cohort was obtained from the Austrian Central Death Register. Overall, 96 of a total of 226 patients (42.5%) died between 1983 and 2006; 37 patients (38.5%) died due to HIV-infection, 15 due to HCV infection, 15 due to bleeding (15.6%, respectively) and 29 (30.2%) due to various other causes. The mortality of HIV-positive patients was 74.3% (n = 55) and that of HCV-positive patients was 40.4% (n = 55) in the analysed period. The patient mortality rates were compared with those of the general Austrian male population following adjustment for age and calendar period. We found that the cumulative relative survival of all patients was 0.694 (95% CI 0.614-0.767). The cumulative relative survival of patients with severe haemophilia (FVIII or IX level < or =1%) was 0.489 (0.394-0.579), but was normal (0.986; 95% CI 0.858-1.082) for patients with mild or moderate haemophilia (FVIII or IX level 2-50%). The survival rate was lowest in HIV-positive patients (0.287; 95% CI 0.186-0.398), but was also decreased to 0.874 (0.776-0.951) in HIV-negative patients. It can, therefore, be concluded that the survival of patients with severe haemophilia is still decreased compared to those with non-severe haemophilia and the general male population, regardless of HIV-infection.


Asunto(s)
VIH-1 , Hemofilia A/mortalidad , Hemofilia B/mortalidad , Hepatitis C/mortalidad , Adolescente , Adulto , Anciano , Austria , Niño , Preescolar , Infecciones por VIH/mortalidad , Humanos , Lactante , Masculino , Persona de Mediana Edad , Valores de Referencia , Estudios Retrospectivos , Factores de Riesgo , Análisis de Supervivencia , Adulto Joven
8.
Early Hum Dev ; 123: 1-5, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29935388

RESUMEN

BACKGROUND: International guidelines recommend the use of item based scales for the assessment of pain and sedation. In our previous study, the implementation of the Neonatal Pain Agitation and Sedation Scale (N-PASS), and the associated systematic assessment and treatment of pain and sedation reduced pain and over-sedation in our intervention group, but lead to a significant increase of individual opiate exposure. This increased opiate exposure was not associated with impaired motor and mental development at one year of age. As one-year follow-up is not necessarily representative for future outcomes, we retested our sample at three years of age. METHODS: Fifty-three patients after (intervention group) and 61 before implementation (control group) of the N-PASS and the Vienna Protocol for the Management of Neonatal Pain and Sedation (VPNPS), were compared for motor, mental and behavioural development at three-years follow-up using the Bayley Scales of Infant Development. RESULTS: Cumulative opiate exposure was not associated with mental (p = .31) and motor (p = .20) problems when controlling for other important medical conditions, but was associated to lower behavioural scores (p = .007). No statistically significant differences were found with regard to mental (p = .65), psychomotor (p = .12) and behavioural (p = .61) development before and after the implementation of the N-PASS and the VPNPS. CONCLUSION: Implementing a neonatal pain and sedation protocol increased opiate exposure without affecting neurodevelopmental outcome at three-years of age.


Asunto(s)
Analgésicos Opioides/efectos adversos , Desarrollo Infantil/efectos de los fármacos , Recien Nacido Extremadamente Prematuro/crecimiento & desarrollo , Analgésicos Opioides/administración & dosificación , Estudios de Casos y Controles , Preescolar , Femenino , Humanos , Recién Nacido , Masculino
9.
J Perinatol ; 35(9): 689-94, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25836320

RESUMEN

OBJECTIVE: A negative impact of altitude on birth weight has been demonstrated for medium to high-altitude countries. STUDY DESIGN: The present study aims to show a similar effect for a lower altitude range up to 1600 m in the country of Austria and to adjust for several further risk factors related to mother and infant. In addition, we analyzed whether the effect of altitude influenced birth weight independently or interacted with other factors. For the purpose of this study, almost 1.9 million individual birth certificates of Austrian newborns born between 1984 and 2013 were analyzed. In a multivariate linear regression model, birth weight was associated with altitude of living address and following variables: sex, birth length, gestational age, level of education, maternal age, year of birth, parity, time to previous birth and marital status. RESULT: Birth weight decreased by 150 g/1000 m altitude, demonstrating a clear effect of altitude on birth weight also in a low to medium altitude level. Additionally, we could show that this effect also depends on other factors, namely gestational age, education of the mother, sex, birth length, year of birth and time to previous delivery. All variables interacted significantly (p<0.0001) with altitude. CONCLUSION: We observed a negative effect of altitude in an altitude range up to 1600 m. Furthermore, this effect also depends on other risk factors. Therefore, unadjusted estimates as described in many studies may be biased. This population-based study describes the effect of low-to-medium altitude on birth weight in central Europe over a period of 30 years.


Asunto(s)
Altitud , Peso al Nacer , Retardo del Crecimiento Fetal , Recién Nacido de Bajo Peso , Adolescente , Adulto , Austria/epidemiología , Escolaridad , Femenino , Retardo del Crecimiento Fetal/epidemiología , Retardo del Crecimiento Fetal/etiología , Edad Gestacional , Humanos , Recién Nacido , Masculino , Edad Materna , Embarazo , Historia Reproductiva , Factores de Riesgo
10.
J Clin Endocrinol Metab ; 86(8): 3833-9, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11502820

RESUMEN

Carbon monoxide, a gaseous activator of soluble guanylyl cyclase formed by a subtype of the enzyme heme oxygenase designated heme oxygenase-2 in vascular endothelium, has been found to dilate blood vessels independently from nitric oxide. Because of the parallels between nitric oxide and carbon monoxide, we speculated that estrogen might affect carbon monoxide production in vascular endothelium. Endothelial cells of human origin (umbilical vein and uterine artery) were incubated for 4 or 24 h with 10(-12)-10(-6) M 17beta-estradiol. 17beta-Estradiol, at a concentration such as that attained during the ovulatory phase of the menstrual cycle (10(-10) M), administrated for 4 h led to a 2-fold increase in intracellular carbon monoxide production and heme oxygenase-2 protein levels (P < 0.05). A reporter assay, measuring the formation of cGMP as the direct product of carbon monoxide-induced activation of soluble guanylyl cyclase in endothelial cells, also revealed a 56% increase in cellular cGMP after treatment with 10(-10) M E2 17beta-estradiol (P < 0.05). By contrast, higher 17beta-estradiol concentrations had no significant respective effects due to nitric oxide synthase inhibition of carbon monoxide release. This 17beta-estradiol effect appeared to be ER dependent, as preincubation with tamoxifen (10(-6) M) blocked the stimulatory effect of 17beta-estradiol in each instance. Our preliminary data indicate a potential role for carbon monoxide as a biological messenger molecule in estrogen-mediated regulation of vascular tone.


Asunto(s)
Monóxido de Carbono/metabolismo , GMP Cíclico/metabolismo , Endotelio Vascular/fisiología , Estradiol/farmacología , Hemo Oxigenasa (Desciclizante)/genética , Arterias , Células Cultivadas , Relación Dosis-Respuesta a Droga , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Femenino , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Hemo Oxigenasa (Desciclizante)/metabolismo , Hemo-Oxigenasa 1 , Humanos , Cinética , Proteínas de la Membrana , Ciclo Menstrual , Modelos Biológicos , NG-Nitroarginina Metil Éster/farmacología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Venas Umbilicales , Útero/irrigación sanguínea
11.
Aliment Pharmacol Ther ; 18(11-12): 1113-20, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14653831

RESUMEN

BACKGROUND: Antibiotics and thiopurines have been employed in the management of fistulizing Crohn's disease, although evidence of their efficacy is rare. AIM: To evaluate, in a prospective, open-label study, the influence of antibiotics and azathioprine on the clinical outcome of perianal fistulas in patients with Crohn's disease. METHODS: Fifty-two patients entered the study, starting with an 8-week regimen of ciprofloxacin (500-1000 mg/day) and/or metronidazole (1000-1500 mg/day). Seventeen patients had already received daily azathioprine (2-2.5 mg/kg) at enrollment, whereas in 14 patients azathioprine was initiated after 8 weeks of antibiotic treatment. Outcome was evaluated by Fistula Drainage Assessment and the Perianal Disease Activity Index at weeks 8 and 20. RESULTS: Overall, 26 patients (50%) responded to antibiotic treatment, with complete healing in 25% of patients at week 8. The Perianal Disease Activity Index decreased significantly from 8.4 +/- 2.9 to 6.0 +/- 4.0 (P < 0.0001). At week 20, the outcome was assessed in 49 patients (94%), 29 of whom (59%) had received azathioprine. Response was noted in 17 of the 49 patients (35%), with complete healing in nine patients (18%). Patients who received azathioprine were more likely to achieve a response (48%) than those without immunosuppression (15%) (P = 0.03). The Perianal Disease Activity Index was closely associated with treatment response and perianal disease activity. CONCLUSION: Antibiotics are useful to induce a short-term response in perianal Crohn's disease, and may provide a bridging strategy to azathioprine, which seems to be essential for the maintenance of fistula improvement.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Antibacterianos , Enfermedades del Ano/tratamiento farmacológico , Azatioprina/administración & dosificación , Enfermedad de Crohn/tratamiento farmacológico , Quimioterapia Combinada/administración & dosificación , Fístula Rectal/tratamiento farmacológico , Adolescente , Adulto , Anciano , Ciprofloxacina/administración & dosificación , Femenino , Estudios de Seguimiento , Humanos , Masculino , Metronidazol/administración & dosificación , Persona de Mediana Edad , Estudios Prospectivos , Recurrencia , Resultado del Tratamiento
12.
Aliment Pharmacol Ther ; 17(11): 1371-80, 2003 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-12786631

RESUMEN

BACKGROUND: Conventional non-steroidal anti-inflammatory drugs have been associated with an increased risk of exacerbation of inflammatory bowel disease. AIM: To evaluate, in a prospective, open-label study, the safety and efficacy of a 20-day regimen of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, 12.5-25 mg/day, in inflammatory bowel disease patients with associated peripheral arthropathy and/or arthritis. METHODS: Patients with clinically inactive to mild inflammatory bowel disease and a joint pain score of at least two points on a scale ranging from zero (none) to four (very poor) were eligible. Response was defined by a decrease of at least two points in the arthralgia score. RESULTS: Of the 32 patients included, 26 (81%) were treated with rofecoxib, 25 mg/day, and six (19%) with rofecoxib, 12.5 mg/day. In three patients (9%), rofecoxib had to be withdrawn after a few days due to gastrointestinal complaints which ceased immediately after drug discontinuation. No flare of inflammatory bowel disease occurred. Thirteen of the 32 patients (41%) were responders and, overall, the arthralgia score decreased from two to one (P = 0.0001). CONCLUSIONS: This is the first prospective study on the use of a selective cyclo-oxygenase-2 inhibitor in inflammatory bowel disease patients with peripheral arthropathy and/or arthralgia. The promising safety and efficacy profile warrants further evaluation in controlled trials.


Asunto(s)
Artralgia/complicaciones , Artritis/complicaciones , Inhibidores de la Ciclooxigenasa/administración & dosificación , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Isoenzimas/antagonistas & inhibidores , Lactonas/administración & dosificación , Adulto , Anciano , Ciclooxigenasa 2 , Inhibidores de la Ciclooxigenasa 2 , Inhibidores de la Ciclooxigenasa/efectos adversos , Evaluación de Medicamentos , Humanos , Enfermedades Inflamatorias del Intestino/complicaciones , Lactonas/efectos adversos , Proteínas de la Membrana , Persona de Mediana Edad , Dimensión del Dolor , Estudios Prospectivos , Prostaglandina-Endoperóxido Sintasas , Sulfonas , Resultado del Tratamiento
13.
J Clin Epidemiol ; 50(2): 159-65, 1997 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9120509

RESUMEN

The analysis of the seasonal pattern of incidence of childhood insulin-dependent diabetes mellitus in Austria was carried out among cases where the child was under the age of 15 when diagnosed between 1979 and 1993. The cases are registered in the nationwide population-based Austrian insulin-dependent diabetes mellitus registry. Seasonal variation was compared between boys and girls and between three 5-year age groups. We also tested whether the seasonal pattern changed over the 15-year observation period. We found a significant seasonal variation among boys aged 10-14 and girls aged 5-14, while in the 0-4 years age group no seasonal pattern could be demonstrated. Two peaks in incidence were identified during a calendar year (February-March and September-October) for girls aged 5-14. For boys aged 10-14, a yearly cycle was found with a peak in January and October. An extension of the Poisson regression model for testing seasonality by Jones et al. was developed to allow for estimation of a time-dependent amplitude of the seasonal component. The annual incidence rate increased by 36% during the observation period, but no significant change in seasonal pattern could be demonstrated.


Asunto(s)
Diabetes Mellitus Tipo 1/epidemiología , Estaciones del Año , Adolescente , Austria/epidemiología , Niño , Preescolar , Femenino , Humanos , Incidencia , Lactante , Masculino , Modelos Estadísticos , Periodicidad , Distribución de Poisson
14.
J Clin Epidemiol ; 56(9): 891-5, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-14505775

RESUMEN

BACKGROUND AND OBJECTIVE: Despite the importance of autopsies for diagnosing disease and determining cause of death, autopsy rates are decreasing in many countries. Furthermore, autopsy rates are often not distributed randomly between different regions within countries. In this study we analyzed an apparent nonrandom spatial distribution of autopsy rates in Austria for the period 1991-2000. We tested the new hypothesis that the rate of autopsies performed on people who die at home depends on the distance from the residence to the hospital or forensic institute where autopsies are performed. METHODS: Data were extracted from the official mortality records for the years 1991-2000. Only persons who deceased in private residences were included. A logistic regression model was used. RESULTS: Even controlling for variability in sex, age, date of death, and family status, the effect of distance significantly implied lower autopsy rates in the alpine parts of Austria. CONCLUSIONS: This effect of distance may lead to artificially nonrandom mortality patterns in disease maps. As a consequence, the possibility of hypothesizing incorrect health risks to explain nonrandom mortality patterns increases.


Asunto(s)
Autopsia/estadística & datos numéricos , Ambiente , Austria , Autopsia/economía , Causas de Muerte , Costos y Análisis de Costo , Humanos , Modelos Logísticos , Sensibilidad y Especificidad
15.
Eur J Cancer Prev ; 10(5): 425-8, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11711757

RESUMEN

The aim of the study was to assess the impact of prostate-specific antigen (PSA) testing on prostate cancer mortality in Austria. A join-point regression model and permutation tests were used to identify changes in the slope of age-specific trends respectively calculating the annual percentage change (APC). Age-adjusted incidence increased (P < 0.01) between 1983 and 1997 by 79% from 52.2 to 93.6 cases per 100 000 men/year. Incidence in localized/regional stage disease increased in all ages by 143% from 25.7 to 62.4 cases per 100 000 men/year. Incidence in distant disease decreased (P < 0.01) between 1983 and 1997 in all ages by 38% from 9.5 to 5.9 cases per 100 000 men/year. Incidence in unstaged disease increased (P < 0.01) between 1983 and 1997 in all ages by 300% from 4.5 to 18 cases per 100 000 men/year. Age-adjusted mortality increased (P < 0.05) by 13% from 26.8 in 1983 to 30.3 deaths per 100 000 men/year in 1999. No significant changes of trends in mortality rates were detected in the age groups 50-59 years. In the age group 70-79 years the trend changed (P < 0.05) direction in 1991 and in 1994; 1983 through 1991 APC = 3.52 (95% CI 1.37, 5.72), 1991 through 1994 APC = -10.27 (95% CI -26.20, 9.1) and 1994 through 1999 APC = -0.25 (95% CI -4.55, 4.24). PSA testing increased incidence but no impact on mortality in the target population can be observed so far.


Asunto(s)
Antígeno Prostático Específico/sangre , Neoplasias de la Próstata/sangre , Neoplasias de la Próstata/epidemiología , Distribución por Edad , Anciano , Austria/epidemiología , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Análisis de Regresión
16.
Eur J Cancer Prev ; 8(1): 49-55, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10091043

RESUMEN

The aim of this study was to assess the overall progress against cancer in Austria by analysing changes in age-adjusted mortality rates from 1970 to 1996. For the years 1970 to 1996, age-adjusted rates for all malignant neoplasms and for selected sites were calculated for men and women, according to year, age and sex. The number of cancer deaths were obtained from the Austrian Central Statistical Office--age-adjusted mortality rates of all malignant neoplasms decreased in men between 1971 and 1996 by 13% (from 289.1 to 251.4 deaths per 100,000), and in women between 1970 and 1996 by 19.1% (from 276.6 to 223.7 deaths per 100,000). Among older people (> or = 55 years) the mortality decreased by 13% in men and by 17% in women; among younger people (< 55 years) by 12% and 30%, respectively. The decrease in total cancer mortality is promoted by three tumour sites (the leading causes of cancer deaths in 1970). In both sexes, the decrease of stomach cancer mortality had the major impact, followed by colorectal cancer in women and by lung cancer in men. The observed changes in mortality are primarily related to changing incidence and early detection, rather than improvements in treatment. Unfortunately, there is evidence that prevention is losing ground in Austria. The implementation of the well-established knowledge of cancer prevention and the strengthening of preventative research is urgently needed.


Asunto(s)
Neoplasias/mortalidad , Adolescente , Adulto , Factores de Edad , Austria/epidemiología , Niño , Preescolar , Neoplasias del Colon/mortalidad , Femenino , Humanos , Incidencia , Lactante , Neoplasias Pulmonares/mortalidad , Masculino , Tamizaje Masivo , Persona de Mediana Edad , Neoplasias/diagnóstico , Neoplasias/epidemiología , Neoplasias/prevención & control , Neoplasias del Recto/mortalidad , Factores Sexuales , Neoplasias Gástricas/mortalidad
17.
J Investig Med ; 48(6): 449-56, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11094868

RESUMEN

BACKGROUND: Interleukin-10 (IL-10) exhibits potent anti-inflammatory and immunosuppressive activities in vitro. Recent data indicate that treatment with recombinant human IL-10 (rHuIL-10) Crohn's disease is safe and may induce clinical and endoscopic remission. The present study investigates the in vivo immunomodulatory properties of rHuIL-10 in inflammatory bowel disease (IBD). METHODS: As part of two randomized, double-blinded, placebo-controlled trials, repeated flow cytometric analyses of lymphocyte phenotypes (CD3, CD4, CD8, CD16 + 56, CD19) and activity markers (human leukocyte antigen [HLA]-DR; intercellular adhesion molecule-1 [ICAM-1]; IL-2-receptor alpha [IL-2R alpha]; high affinity receptor for immunoglobulin G [IgG; Fc gamma RI]) on T cells, monocytes, and neutrophils were performed in 17 patients with IBD who received rHuIL-10 (5, 10, or 20 micrograms/kg) or placebo, administered subcutaneously, once daily for 28 days. RESULTS: Minor changes were noted in CD3+, CD8+, and CD3+/CD16 + 56+ lymphocyte phenotypes, whereas absolute numbers of CD4+ lymphocytes and CD19+ cells increased. T-cell activation markers HLA-DR and IL-2R alpha were downregulated. rHuIL-10 did not influence HLA-DR expression on monocytes. ICAM-1 modulation on monocytes and neutrophils was mild and inconsistent. Fc gamma RI expression was upregulated on both neutrophils and monocytes. CONCLUSIONS: These data indicate that the immunosuppressive effects of rHuIL-10 treatment are partly different from its in vitro observed actions. The increase of the cytotoxicity-mediating Fc gamma RI points to potential immunostimulating properties of this cytokine.


Asunto(s)
Inmunosupresores/farmacología , Enfermedades Inflamatorias del Intestino/inmunología , Interleucina-10/farmacología , Linfocitos/efectos de los fármacos , Adulto , Método Doble Ciego , Femenino , Antígenos HLA-DR/análisis , Humanos , Inmunofenotipificación , Molécula 1 de Adhesión Intercelular/análisis , Masculino , Persona de Mediana Edad , Receptores de IgG/análisis , Receptores de Interleucina-2/análisis , Proteínas Recombinantes/farmacología
18.
Wien Klin Wochenschr ; 110(13-14): 485-90, 1998 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-9746962

RESUMEN

Mammography for breast cancer screening has been available in Austria free of charge since 1974 and has been explicitly recommended for mass screening since 1980. The type of screening is opportunistic. Evaluation has to rely on population-based data (mortality, stage distribution, screening prevalence). In a representative cross-sectional study (women aged 40-79 years, n = 566, conducted in 1995) 58% reported at least one screening mammography; the lowest prevalence was found in the age group 70-74 years: 39.3%, the highest in the age group 50-54 years: 71.4%. 23.1% reported at least 2 mammograms within an interval of less than 2 years; lowest prevalence 70-74 years: 10.7%, highest 50-54 years: 35.7%. Age-standardized mortality rate has stabilized since 1985. Since 1980 age-specific rates have increased significantly in all age groups > 54 years, but a decreasing tendency in most groups has been noted since around 1990. The incidence rates of stage II or worse tumors have increased significantly since 1982, except in the age groups 40-44 and 55-59 years; however, during the past 3 to 6 years the absolute rates of incidence of advanced tumors has decreased in alle age groups. The reduction of advanced cancers at diagnosis, followed by a reduction of mortality rates is plausible related to screening prevalence. More uniform decreasing trends should be expected in the years to come. If not, discontinuation of the current opportunistic form of screening without monitoring and evaluation, financed by public money, has to be discussed.


Asunto(s)
Neoplasias de la Mama/mortalidad , Mamografía/estadística & datos numéricos , Tamizaje Masivo/estadística & datos numéricos , Adulto , Anciano , Austria , Neoplasias de la Mama/patología , Neoplasias de la Mama/prevención & control , Femenino , Humanos , Persona de Mediana Edad , Estadificación de Neoplasias
19.
Wien Klin Wochenschr ; 108(20): 643-8, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8940769

RESUMEN

We assessed the risk of stillbirth in Austria during 1984-1993 in dependence of the variables maternal age, birth weight, year of birth and sex. All children born in Austria between 1984 and 1993 were included in the study (905,939 births). The risk of stillbirth was estimated by means of a logistic regression model. During the study period, stillbirths decreased significantly in Austria. Both birth weight and maternal age had a non-linear association with the risk of stillbirth. The lowest stillbirth rate was in the birth weight category of 3300-3899 grams (g). Of all stillbirths 62% occurred in infants weighing < or = 2500 g at birth. We also found a significant interaction between birth weight and year of birth suggesting that the effect of birth weight was not stable over the years. The proportion of young mothers (< 20 years) decreased clearly over the observation period. The proportion of low birth weight (< = or 2500 g) infants remained around 7.5% during the 10-year period, but the stillbirth rate decreased linearly over time in this group. In infants weighing > 2500 g at birth the stillbirth risk decreased during first five years but started to increase thereafter. Since over 60% of stillbirths in Austria occur in the low birth weight category, it is obvious that more effective strategies are needed for prevention of low birth weight births and fetal immaturity. In addition, further efforts are needed to prevent also high birth weight of newborns particularly in diabetic mothers.


Asunto(s)
Peso al Nacer , Muerte Fetal/epidemiología , Edad Materna , Adolescente , Adulto , Austria/epidemiología , Estudios Transversales , Femenino , Humanos , Incidencia , Recién Nacido de Bajo Peso , Recién Nacido , Modelos Logísticos , Masculino , Persona de Mediana Edad , Embarazo , Análisis de Regresión , Factores de Riesgo
20.
Wien Klin Wochenschr ; 111(9): 354-9, 1999 May 07.
Artículo en Inglés | MEDLINE | ID: mdl-10407996

RESUMEN

Pap smear screening was introduced in Austria in the late 1960's and was recommended annually for all women older than 20 years ever since. This is an opportunistic screening. The evaluation has to rely on population based data (mortality, stage distribution, screening prevalence). In a representative cross-sectional study (women aged 20-69 years, n = 933, conducted in 1995), 76% reported at least one Pap screening during their life; the highest prevalence (88%) was reported by women aged 50-59 years, the lowest prevalence (65%) by women aged 60-69 years. Forty-eight per cent of all women reported that they had undergone screening at least 4 times (40-49 years: 57%, 20-29 years: 34%). Between 1980 and 1996, mortality due to cancer of the uterus, part unspecified (ICD-9: 179), decreased by 54% (P = 0.0001) and that of cancer of the cervix (ICD-9: 180) by 44% (P = 0.0001). Since 1980, age-specific incidence rates of invasive disease decreased (P = 0.0001) in all 10-year age groups (20-29 years: -59%, 30-39 years: -48%, 40-49 years: -34%, 50-59 years: -62%, 60-69 years: -59%). The incidence of preinvasive disease increased significantly (P = 0.001) in the age groups 20-29 years by 30% and 30-39 years by 45%, respectively. No significant changes are observed in other age groups. Opportunistic screening has reduced mortality from cervical cancer and particularly limited the increase among younger women, but the high proportion of cancer deaths from uterine cancer, in part unspecified, obscures the actual trend. We estimate that the true mortality from cervical cancer has been nearly halved between 1980 and 1996. Most of this reduction must be attributed to the screening activities in the 1970's and we expect a further decrease as a result of the expanded screening activities in the 1980's.


Asunto(s)
Tamizaje Masivo/estadística & datos numéricos , Prueba de Papanicolaou , Neoplasias del Cuello Uterino/mortalidad , Frotis Vaginal/estadística & datos numéricos , Adulto , Anciano , Austria/epidemiología , Causas de Muerte , Estudios Transversales , Femenino , Encuestas Epidemiológicas , Humanos , Incidencia , Persona de Mediana Edad , Estadificación de Neoplasias , Análisis de Supervivencia , Neoplasias del Cuello Uterino/patología , Neoplasias Uterinas/mortalidad , Neoplasias Uterinas/patología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda